The company behind the drug donanemab said it will ask regulators to reconsider the decision. View on euronews ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use issued an opinion that does not recommend Eli Lilly (LLY) and ...

Strategic investments, workforce readiness, and pioneering initiatives are attracting leading life sciences companies to ...

Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

Through Synapticure, patients will be able to use LillyDirect to find in-person Alzheimer’s specialists or to connect with ...

The executives leading Hippocratic AI's healthcare sector and international expansion efforts are: ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

This is part two of IndyStar's oral history recounting the national blowback to the Religious Freedom Restoration Act in 2015 ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Korean automaker Hyundai is the latest to announce plans to boost investment in the U.S. to ramp up domestic manufacturing.